Online Launch: “Launch of the WHO/Europe Signature Initiative to reduce inequalities in cardiovascular disease burden and high blood pressure prevalence through improving hypertension control in primary care and implementing salt-reduction strategies [‘CVD Signature Initiative’].”
Date: 9 December 2022, 11:00-12:30 CET
Registration link: https://who.zoom.us/webinar/register/WN_oklk9CC1T-y-a-bUi9mJFg
About: High blood pressure is the leading risk factor for CVD burden. In 2019, hypertension led to 13% of disability-adjusted life-years across the WHO European Region and was the cause of 24% of all deaths from CVD. Member States in the eastern part of the Region have some of the highest rates of hypertension globally, with an overall prevalence of 39%, and some of the highest consumption levels of salt globally.
The Regional Director for Europe has initiated an NCD Advisory Council for Innovation in Noncommunicable Diseases. This has six Signature Initiatives including the Signature Initiative to reduce inequalities in cardiovascular disease burden and high blood pressure prevalence through improving hypertension control in primary care and implementing salt-reduction strategies. This ‘CVD Signature Initiative’ will be pragmatic and practical. Taking person-centred, facility-based and population-level approaches, the following strategies will be employed by WHO to reduce inequalities in the CVD burden.
This specific event will present the CVD Signature Initiative and will include the size of the problem, what works, examples of good practice, and how countries might participate. It is intended to be of particular interest to countries at high burden for CVD mortality, with high hypertension prevalence or salt intake, and/or with poor detection, treatment and control of hypertension.
The working language of the meeting will be English, and simultaneous interpretation in Russian will be provided.
Please spread to your network.
WHO European Office for Prevention and
Control of Noncommunicable Diseases (NCD Office)